Why Be Optimistic if the Payers Are Cautious?

Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Bottom-Up

<p>Leading U.S. pharmacy benefits manager <a href="https://www.smartkarma.com/entities/7211" target="_blank" data-smartkarma-citation="entities:7211">Express Scripts (ESRX US)</a> held a conference call today to discuss its Q2: 2016 results. The company is the largest manager of drug benefits in the U.S., processing over 1.2 billion drug claims annually (estimated 29% market share). Management has a track record of taking high-profile stances to get lower prices in negotiating with drug companies. As such, their comments carry great weight in the market.</p><p>CEO Tim Wentworth spoke about the outlook for…</p>

Leading U.S. pharmacy benefits manager Express Scripts (ESRX US) held a conference call today to discuss its Q2: 2016 results. The company is the largest manager of drug benefits in the U.S., processing over 1.2 billion drug claims annually (estimated 29% market share). Management has a track record of taking high-profile stances to get lower prices in negotiating with drug companies. As such, their comments carry great weight in the market.CEO Tim Wentworth spoke about the outlook for…

Celltrion Inc

Another Payer Speaks Cautiously